Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword
J. Clin. Invest. Alberto Pugliese, et al. 111:1280 doi:10.1172/JCI18395 [Go to this article.]

Table 1
Key proinsulin peptides, their respective MHC binding capacities, and induced T cell responses